BOYCE SARAH (President and CEO) sold 5.1% of their position (14.39K shares) of AVIDITY BIOSCIENCES, INC. on the open market
Open‑market sale worth $1.04M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/23/2026ACC: 0001599901-26-000025
DirectorOfficer· President and CEO
Since Jun 2020
-14.39K
Net shares
Net seller
$1.04M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
14.39K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−6.39K
Price / share
$72.45
Trade value
$463.25K
% of position
2.3%
1/21/2026
283.39K→277K
Common Stock
Direct
Shares
−7.99K
Price / share
$72.45
Trade value
$579.09K
% of position
2.9%
1/21/2026
277K→269.01K
Total
Net shares
−14.39K
Net value
-$1.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | S · Sale | −6.39K | $72.45 | $463.25K | 2.3% | 283.39K | 277K |
| Common Stock Direct | 1/21/2026 | S · Sale | −7.99K | $72.45 | $579.09K | 2.9% | 277K | 269.01K |
| Total | −14.39K | -$1.04M | ||||||
Derivative Transactions0
No derivative transactions reported